Monday, 12 March 2018

Anthera to explore options after lead drug's trial failure

(Reuters) - Anthera Pharmaceuticals Inc said on Monday it would evaluate all strategic options after its lead drug failed in a late-stage trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)